Acadian Asset Management
TSBX

Acadian Asset Management’s Turnstone Biologics TSBX Stock Holding History

Acadian Asset Management’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,430
Closed -$4K – 2012
2025
Q2 		$4K Sell
16,430
-1,403
-8% -$492 ﹤0.01% 1629
2025
Q1 		$6K Hold
17,833
– – ﹤0.01% 1565
2024
Q4 		$7K Sell
17,833
-18,621
-51% -$9.2K ﹤0.01% 1567
2024
Q3 		$19K Buy
+36,454
New +$56K ﹤0.01% 1984

Acadian Asset Management's TSBX Position: Q3 2025 in Review

Acadian Asset Management sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 16,430 shares — an estimated $4K sold.

Acadian Asset Management first reported a position in TSBX in Q3 2024 and held it in 4 quarters. The position peaked at $19K in Q3 2024. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

  • Acadian Asset Management reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
  • Acadian Asset Management sold 16,430 Turnstone Biologics shares in Q3 2025, an estimated $4K.
  • Acadian Asset Management first reported a position in Turnstone Biologics in Q3 2024 and held it in 4 quarters.
  • Acadian Asset Management's Turnstone Biologics position peaked at $19K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on Acadian Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.